The EBSCO eBooks app is available for:
|
Thursday, 13 August 2015
The EBSCO eBooks app is now available!
The EBSCO eBooks app enables easy discovery and simple download capabilities from your library collection to any mobile device, and a best-in-class reading experience.
Monday, 18 May 2015
We're gone for the summer
Tuesday, 12 May 2015
Monday, 11 May 2015
Friday, 1 May 2015
Artificial Pancreas During Pregnancy - Breakthrough
The new mother-of-two has Type 1 diabetes and wore the piece of kit throughout her pregnancy to produce insulin and prevent symptoms of the disease.
Three other mothers have previously given birth in Cambridge after using the device but by caesarean section.
An artificial pancreas device system (APDS) is a small portable piece of equipment designed to carry out the function of a healthy pancreas.
It helps to control blood glucose levels using digital communication technology to automate insulin delivery.
An APDS is worn on the body during pregnancy and has a continuous glucose monitor (CGM), a digital controller and an insulin pump.
Dr Helen Murphy, principal investigator of the study Ms Finlayson-Wilkins took part in, said Euan's arrival was an exciting step in the treatment of diabetes in pregnancy.
"Women who have diabetes in pregnancy face higher rates of birth defects, over-sized babies, pre-term delivery and stillbirth than other pregnant women," she said.
"Treating diabetes in pregnancy can be particularly challenging because hormone levels are constantly changing and blood sugars can be difficult to predict."
The results of the ongoing National Institute for Health Research's Closed Loop in Pregnancy study are due to be published later this year.
Its findings could mean the technology benefits more pregnant women with diabetes.
One in five trainee doctors ‘may need mental health support’
Twenty per cent of
doctors training for senior posts may be in need of support for mental health
issues, a survey by the Medical Council has found.
Trainees
who reported experiencing bullying and those who worked longer hours were more
likely to have poorer health and wellbeing.
Some
29 per cent of trainees felt they need to access support services for their
health and wellbeing but the vast majority didn’t actually do so, according to
the survey.
The
report by the Medical Council says a small but significant minority of trainees
are clearly struggling to maintain good quality of life and mental health and
wellbeing.
Almost
20 per cent of trainees described their quality of life as poor; those in
bigger teaching hospitals were more likely to report an inferior quality of
life.
The
report says hospitals appear to present particular challenges to maintaining
good health and wellbeing.
“This
report finds a strong, significant and consistent link between the experience
of bullying and undermining and poorer health and wellbeing among trainees,” it
says.
It
says there is a role for training organisations to ensure self-awareness and
self-care are fostered to help trainees maintain good health and wellbeing.
“But a wider response involving policy-makers and healthcare organisations is
required to ensure that the clinical environments where trainees work and learn
are designed and managed to prevent unnecessary challenges for trainee health
and wellbeing so problems are prevented,” it says.
CarolineSpillane, chief executive of the Medical Council, said: “Doctors in training
need support to maintain good health and wellbeing in the interest of patient
care through building awareness of these issues and skills for appropriate
self-care into medical education and training curricula.
“There
is ample evidence to show that doctors with good health provide safer and more
effective care to patients, are more engaged in their work, have better
attendance, and are less likely to experience burnout and compassion fatigue.”
More
than 1,600 medical interns and specialist trainees contributed to the survey.
Thursday, 30 April 2015
'Heart attack breakthrough' - Research
Scientists have discovered a way to stimulate muscle cell growth in the heart, limiting the damage to this vital organ after a heart attack
“Unlike blood, hair or skin cells, which can renew themselves throughout life, cell division in the heart virtually comes to a standstill shortly after birth, which means the heart can’t fully regenerate if it is damaged later in life,” Professor Harvey explained.
“Previous studies have demonstrated that it is possible to coax heart muscle cells to proliferate again, but only at very trivial levels.
“What the research team has been able to do is boost heart muscle cell numbers by as much as 45% after a heart attack. That’s a huge improvement!”
Scientists focused on a signalling system in the heart driven by a hormone called ‘neuregulin’.
By switching the neuregulin pathway to ‘turbo charge’ the researchers found that heart muscle cells continued to divide in a spectacular way in both the adolescent and adult periods.
Stimulating the neuregulin pathway during a heart attack lead to replacement of lost muscle.
The study has been published in Nature Cell Biology. To read more click here
View more on Health Canal
Tuesday, 28 April 2015
€30 Million SFI Investment in Scientific Research
Dr Laoise McNamara's project on osteoporosis was one of three NUI
Galway projects funded.
Minister for Skills, Research and Innovation, Damien English TD today announced over €30 million of research funding for 23 major research projects. The Programme will provide funding over a four to five year period, for 23 research projects involving over 100 researchers. Funding for each project will range from €500,000 to €2.3 million.
Three of the projects are led by NUI Galway researchers, and in
partnership with University of Limerick, are significantly involved in a fourth
project.
Two of the projects are listed below:
Two of the projects are listed below:
Dr Laoise McNamara, NUI Galway - This research project will advance
understanding of mechanobiology to develop treatment approaches for bone
pathologies. Tissues of the human body can adapt in response to mechanical
forces by a cellular process known as mechanobiology. Although
mechanobiological processes are fundamental to normal bone physiology and may
play an important role in the development of osteoporosis, the role of
mechanobiology in bone development and changes occurring during ageing are not
yet fully understood. Moreover mechanobiological responses have not been
targeted as treatments for osteoporosis, nor have they been sufficiently
exploited to develop novel regenerative tissue strategies.
Dr Alan Ryder, NUI Galway - Many drugs for human health are complex
biological molecules like proteins which are made in living cells on an
industrial scale. Both the cell food (media) and the protein products have to
be carefully analysed to make sure that they are good and safe. Both media and
proteins are very complex mixtures that are difficult to analyse. Here we will
build a faster, cheaper, and non-contact way of testing using light to generate
chemical information from these mixtures. This information will then be
analysed using advanced statistical methods (chemometrics) and the results used
to improve manufacturing, and reduce drug costs.
Subscribe to:
Posts (Atom)